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ABSTRACT 
Photodynamic Therapy (PDT) provides a non-invasive, efficient and safe treatment for skin diseases with good cosmetic 
results. These characteristics make this technique more advantageous than radiotherapy or chemotherapy, which present 
limitations in a big number of lesions, are painful in many cases and produce non-satisfactory cosmetic results. We 
present the clinical results obtained at present by this optical technique and a photochemical model of the PDT process 
applied to the skin by means of a topical photosensitizer, in order to find the optimal PDT parameters. Optical 
propagation inside the tissue is calculated by means of the three dimensional Beer-Lambert law, due to its facility to be 
integrated in the differential equations system used to model the photochemical processes involved. With this 
information it is possible to obtain an initial estimation about the optimal drug dose and the optical power required. 
Keywords: Photodynamic therapy, topical photosensitizer, skin disorders, singlet oxygen. 
1. INTRODUCTION
Photodynamic Therapy (PDT) is successfully used in medical praxis to treat skin diseases like basocellular carcinoma or 
actinic keratoses. This technique is mainly based on photochemical reactions. The development of photoquimiotherapy 
involves the interaction between light, a photosensitizer and oxygen in ground state in order to provoke malignant tissue 
destruction. Photosensitizers are drugs which are administered by means of intravenous, oral or topical methods. 
Afterwards, the photosensitizer in ground state concentrates in cancer cells and can become active when light of a certain 
wavelength is directed onto the treated area. During the photochemical reaction, the photosensitizer in triplet state 
interacts with oxygen in ground state. This oxygen makes a transition to singlet state, which is the principal agent of 
cellular cytotoxicity [1]. 
The present application of PDT in medical praxis requires fixed protocols that depend on the photosensitizer supplier [2]. 
These protocols establish the optical parameters of the optical source, mainly power and exposition time, in order to 
assure that the treatment will be carried out with no collateral damage. In this case, every lesion receives the same kind 
of treatment. However, this fact avoids the use of the optimal parameters for the particular lesion we are dealing with. 
In this work we use a photochemical model for the PDT process applied to skin diseases by means of Metvix© topical 
photosensitizer. The different molecular reactions are modelled by means of a differential equations system. This system 
is solved via a numerical method, taking into account its stiff nature. The evolution of the PDT process can be predicted 
for different optical source parameters, and so the treatment effect could be known a priori. 
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In section 2, the main skin pathologies and the clinical PDT application are described. In section 3, the results of our 
clinical PDT study are presented and discussed. The theoretical model for the PDT process and the results obtained are 
included in section 4 and 5, respectively. Finally, the general conclusions are shown in section 6.  
2. SKIN PATHOLOGIES AND CLINICAL APPLICATION OF PDT 
Nonmelanoma skin cancer is one of the most frequent malignant neoplasia in humans [3], and includes skin disorders 
such as basocellular carcinoma, squamous cell carcinoma or actinic keratoses. These pathologies are developed as a 
consequence of an accumulated solar exposition, so people suffering from them use to be more than 60 and with light 
skin. That is the reason why the most usual areas affected are the exposed body parts like the face, the scalp or the 
neckline.   
Nonmelanoma skin cancer appears in the basal epidermal cells and it is originated without presenting a previous lesion. 
Metastasis risk is extremely low, but this kind of cancer is able to provoke great local tissue destruction. Squamous cell 
carcinoma can be basal or spinous, presents a fast growing process and it is more likely to invade other tissues. Previous 
lesions that degenerate in squamous cell carcinoma are actinic keratoses and Bowen disease [4]. Actinic keratoses, 
shown in Fig. 1, is the most frequent premalignant lesion and the main lesion that acts as a precursor of squamous cell 
carcinoma.  
Fig. 1. Photo which shows the appearance of the lesions suffered as a consequence of  actinic keratoses in a 
patient’s hands. 
There are several techniques of treatment for skin cancer like excision surgery, electrocoagulation, cryosurgery, 
micrographic Mohs surgery, radiotherapy, CO2 laser or pharmacological treatments like Imiquimod or 5-fluoracil. The 
choice of one of these techniques is motivated by the localization and size of the lesions, the previous treatments 
employed, the age and preferences of the patient, the skills of the practitioner and the rate cost-effectiveness. However, 
they present limitations in a big number of lesions. They are painful in many cases and the cosmetic results are in general 
non-satisfactory. In this way, PDT provides a non-invasive, efficient, safe and good cosmetic treatment.  
Photodynamic Therapy (PDT) is mainly based on photochemical reactions. The development of photoquimiotherapy 
involves the interaction between light, a photosensitizer and oxygen in ground state in order to provoke malignant tissue 
destruction. Photosensitizers are drugs which are administered by means of intravenous, oral or topical methods. After 
some time, the photosensitizer in ground state concentrates in cancer cells and can become active when light of a certain 
wavelength is directed onto the treated area. During the photochemical reaction, the photosensitizer in triplet state 
interacts with oxygen in ground state. This oxygen makes a transition to singlet state, which is the principal agent of 
cellular cytotoxicity [1]. 
Our PDT research work will focus on the problems that this optical treatment technique currently reports in the case of 
the skin disorders described. The knowledge of these clinical deficiencies sets up the modelling approach requirements. 
In order to know and improve the clinical PDT procedure, we have studied different PDT treatment aspects together with 
the Department of Dermatology of the Marqués de Valdecilla University Hospital. Next section shows some of the most 
relevant results we have obtained. 
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3. CLINICAL STUDY OF  PDT 
The PDT procedure involves the application of the topical photosensitizer (methyl aminolevulinate, Metvix©) followed 
by the exposure to its activating light source during eight or nine minutes. Then, the photochemical reactions will take 
place to selectively destroy tumour cells. 
From April 2006 until January 2009, a total of 57 patients suffering from 71 skin disorders were treated at the PDT 
Service of the Marqués de Valdecilla University Hospital. The kind and number of skin diseases which have been treated 
are listed in Table 1, and as it is shown, the majority of patients suffered from actinic keratoses and basocellular 
carcinoma. 
Table1. Distribution of skin diseases treated by PDT. 
Regarding the response of the patients to the treatment, quite good results have been obtained without relevant side 
effects. These effects are mostly heat and slight pain (72 % of the cases), and they appear in the great majority of the 
cases (74 %), as depicted in Fig.2. This feature constitutes, together with the non-invasive characteristic of PDT, the 
most important advantage opposite other tumour treatment techniques. 
Fig.2. Side effects distribution during PDT, showing the number of patients who suffered side effects (a) and the type (b). 74 
% of the whole treated patients (57) suffered side effects during PDT, mostly heat and slight pain which represent the 
72 % of whole registered cases. 
Nonetheless, in several cases these results are not as successful as expected and the disorder appears again, as it is 
expressed by the recurrence index for the 3/6/12 months checkups that can be observed in Table 2. The disease 
recurrence is the principal problem which must be solved, and more specifically in the case of nodular basocellular 
carcinoma, which represents the 60 per cent of the total recurrent cases (see Table 3). 
Table 2. Recurrence index for the different checkups. 
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Table 3. Percentage of the total recurrence for each kind of skin disease. 
4. THEORETICAL MODEL 
Modeling the PDT photochemical process requires the adequate knowledge of optical distribution inside the tissue. 
Among the several optical propagation models that exist, in this work we use the three dimensional Beer-Lambert law, 
due to its facility to be integrated in the photochemical system. The expression of this Beer-Lambert law is: 
The steady-state light distribution can then be calculated. The irradiance changes through the tissue sample and this is 
one of the parameters we should use in the photochemical model. For that purpose, it is necessary to know the photon 
density by means of the following equation: 
Prior predictive analysis was based on a simplified model for the photochemical processes involved. In this work, the 
photochemical model is based on a differential equations system that was already used by Foster et al [1] for a Type II 
PDT process in the time domain, and later improved by a research group of East Carolina and Maryland Universities that 
introduced the photobleaching of the photosensitizer by means of the term which includes the photobleaching constant, 
kpb, in the equations bellow [5]. In this model, a set of rate equations are solved to describe molecular reactions that takes 
into account the transitions between states of the particles involved, like the photosensitizer or the oxygen. These 
equations are based on the Jablonski diagram for the singlet oxygen production, which is considered to be responsible for 
the malignant cells damage. 
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In these equations, 1[ ]iS  is the initial concentration of the photosensitizer in singlet excited state; [ ]iT is the initial 
concentration of photosensitizer in triplet excited state; 3 2[ ]iO  the initial concentration of oxygen in ground state; 
1
2[ ]iO is the initial concentration of singlet oxygen; [ ]iR  the initial concentration of singlet oxygen receptors; [ ]iC  is the 
scavenger concentration; 1  is the relaxation time from state 1S  to 0S ; 3  is the relaxation time from state T  to 0S ; 0
the relaxation time from state 1 2O  to 
3
2O ; 10 is the quantum yield of the transition from state 1S  to 0S ; 13  is the 
quantum yield of the transition 1S  to T ; 30 is the quantum yield of T  transition to 0S ; 0 is the quantum yield of 
1
2O
transition to 3 2O ; S  is the efficiency factor for energy transfer from T  to 
3
2O ; kpb  stands for the biomolecular 
photobleaching rate; kcx  is the biomolecular cytotoxicity rate;  is light speed in tissue;  is the photon density; 
psa  is the absorption cross-section of 0S  molecules; P  is the rate of oxygen diffusion and perfusion; and U  is the 
cell damage repair rate. 
Throughout the photochemical process, complex reactions take place that involve multiple parameters, therefore 
predictions will be determined by this parameters choice. In this case, the values used have been obtained from several 
works [6].   
5. RESULTS 
The complete photochemical model was implemented for the particular case of PDT applied to the skin. The results 
obtained represent a graphical description of the different concentrations of photosensitizer, oxygen and singlet oxygen 
receptors for every point and temporal instant in the tissue sample. The parameters have been reported in several studies 
[7], [8], [9], [10]. 
By solving equations 3 to 8 for different values of photosensitizer concentration and photon density at every point of the 
tissue sample, we obtained the time dependence of the concentrations of photosensitizer, oxygen molecules and singlet 
oxygen receptors. We present one of the results obtained in Figure 3. 
Fig. 3 This graphic describes the time dependence of the concentrations of photosensitizer in ground and excited state, of 
oxygen in ground and singlet state, and of singlet oxygen receptors for  20.05 /Io W cm  and 12 30[ ] 1 10iS cm  at 2.7 
mm from tissue surface. 
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As it can be observed in Fig. 3, the concentration of ground state molecules of photosensitizer, oxygen in ground state 
and receptors vary slowly in response to the activation light while the concentration of the triplet state molecules of 
photosensitizer and singlet oxygen begin to increase slowly until they reach a maximum value. It is supposed that this 
maximum in singlet oxygen concentration produces the desired cytotoxic effect, so we have made several simulations in 
order to adjust the optimal drug and light dose which will produce this effect in the shortest period of irradiation and for 
the largest depth of action in cancerous tissues.  
The temporal dependence of the different concentrations involved in the photochemical reaction is shown in Fig. 3, and 
allow us to obtain an estimation about cytotoxicity and photobleaching by means of intracellular unoxidised receptors 
concentration and ground state molecules of photosensitizer, which could be used later in the development of  cellular 
damage models.  
The simulations executed permit to observe how the temporal instant for the maximum singlet oxygen varies depending 
on the drug dose and the optical power we use. Besides, we can know how much time is needed for different depths in 
the tissue. Therefore, as long as the light passes through the tissue, the irradiance is reduced as long as the intracellular 
oxidised receptors diminish, so the desired cellular damage would not take place in deeper depths in the tissue. 
If we use an insufficient light or drug dose, the singlet oxygen concentration would not increase enough to produce the 
desired cytotoxic effect and tumour cells would not be damaged. As we increase both parameters, singlet oxygen 
concentration would increase and intracellular unoxidised receptors would decrease more rapidly. However, there are 
some limits related to the light dose choice, because it can provoke a dangerous thermal effect if it is too high. In our 
simulations we can observe that the light dose which allows the treatment to reach the maximum depth in the tissue with 
the desired cytotoxic effect is about 20.05 /W cm  using a photosensitizer concentration of  12 30[ ] 1 10iS cm .  These 
first results must be interpreted carefully, due to the great amount of parameters that are involved in these complex 
photoreactions. Subsequently future research works are required to improve the results obtained and to continue 
developing new accurate models. 
6. CONCLUSION 
Nonmelanoma skin cancer is one of the most frequent malignant neoplasia in humans, which includes basocellular 
carcinoma, squamous cell carcinoma or actinic keratoses. These skin disorders have grown during the last years due to 
an increase of solar exposition of the population, the increase of the longevity or the lack of ozone in the atmosphere.  
Conventional techniques against these pathologies like surgery, electrocoagulation, cryosurgery, radiotherapy or even 
pharmacological solutions present some limitations that are successfully solved by PDT. Among PDT advantages over 
conventional treatment techniques, we could mention non-invasivity, selectivity and the lack of severe collateral effects. 
Nowadays the process of PDT application is carried out by means of stiff protocols, and in this way the efficiency of the 
treatment for the particular problem is not assured, as we can observe in the clinical PDT study that we have presented. 
This clinical study identifies the recurrence of the skin disorders as the main inconvenient of this technique, especially in 
the case of nodular basocellular carcinoma. In order to remove this problem, it will be necessary to adjust all the 
parameters which are involved in the photochemical process like the photosensitizer dose or the optical power, so the 
cytotoxic effect could take place in the treated zone. Therefore, we use a photochemical model of the PDT process as a 
first approximation to develop an accurate model to be applied to preclinical planning of PDT treatment. 
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